Loading...

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy

Although available data are conflicting, psoriasis seems to be associated with an increased baseline risk of malignancy. In addition, some antipsoriatic systemic treatments have been associated with risk of malignancy. There is not enough data on the association of interleukin (IL)-17 and IL-23 inhi...

Full description

Saved in:
Bibliographic Details
Published in:Case Rep Dermatol
Main Author: Gambardella, Alessio
Format: Artigo
Language:Inglês
Published: S. Karger AG 2019
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816125/
https://ncbi.nlm.nih.gov/pubmed/31662733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501993
Tags: Add Tag
No Tags, Be the first to tag this record!